| Daily Unique Visitors: | 5,783 |
| Daily Pageviews: | 23,132 |
| Income Per Day: | No data |
| Estimated Worth: | No data |
| Google Indexed Pages: | No data |
| Yahoo Indexed Pages: | No data |
| Bing Indexed Pages: | No data |
| Google Backlinks: | No data |
| Bing Backlinks: | No data |
| Alexa BackLinks: | No data |
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | No data |
| WOT Trustworthiness: |
|
| WOT Privacy: |
|
| WOT Child Safety: |
|
| Total IFRAMEs: | 1 |
| Total Images: | 101 |
| Google Adsense: | No data |
| Google Analytics: | UA-33549717-1 |
| Alexa Rank: | 235,180 |
| PageSpeed Score: | 51 out of 100 |
| Domain Authority: | No data |
Location Latitude:
25.7863Location Longitude:
-80.1898| Domain Registrar: | BR-NIC |
|---|---|
| Registration Date: | 2012-04-27 |
| Last Modified: | 2019-04-13 |
| Expiration Date: | 2020-04-27 |
| Owner's E-Mail: | criacao@corpmedia.com.br |
| Host | IP Address | Country | |
|---|---|---|---|
| ns-1192.awsdns-21.org | 205.251.196.168 | United States |
|
| ns-21.awsdns-02.com | 205.251.192.21 | United States |
|
| ns-1889.awsdns-44.co.uk | 205.251.199.97 | United States |
|
| ns-912.awsdns-50.net | 205.251.195.144 | United States |
|
| Type | TTL | Extra |
|---|---|---|
| A | 285 |
IP: 173.44.38.69 |
| NS | 3585 |
Target: ns-1192.awsdns-21.org |
| NS | 3585 |
Target: ns-1889.awsdns-44.co.uk |
| NS | 3585 |
Target: ns-21.awsdns-02.com |
| NS | 3585 |
Target: ns-912.awsdns-50.net |
| SOA | 900 |
MNAME: ns-1192.awsdns-21.org RNAME: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 |
| MX | 300 |
Priority: 10 Target: mail.corpmedia.com.br |
| TXT | 300 |
TXT: google-site-verification= zx15yLeC6TZQhtBMCTAX8BB07 TuheK5uCxgKmH0cG2w |
| TXT | 300 |
TXT: v=spf1 +a +mx +ip4:173.44.38.60 +ip4:173.44.38.61 +ip4:173.44.38.63 ~all |
Daily news and opinion site based in the U.S., with reports from struggles around the world and left-wing analysis of political events.
235,182
$ 35,100.00
We want to stop prostate cancer being a killer. We fund groundbreaking research, drive improvements in treatment, and fight injustice in care.
235,190
$ 35,100.00